SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-105300
Filing Date
2016-05-27
Accepted
2016-05-27 09:00:21
Documents
5
Period of Report
2016-05-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v441040_8k.htm 8-K 26955
2 EXHIBIT 4.1 v441040_ex4-1.htm EX-4.1 97352
3 EXHIBIT 10.1 v441040_ex10-1.htm EX-10.1 222351
4 EXHIBIT 99.1 v441040_ex99-1.htm EX-99.1 12399
5 GRAPHIC image_001.jpg GRAPHIC 7741
  Complete submission text file 0001144204-16-105300.txt   371184
Mailing Address 2345 EASTLAKE AVENUE EAST SUITE 201 SEATTLE WA 98102
Business Address 2345 EASTLAKE AVENUE EAST SUITE 201 SEATTLE WA 98102 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 161680084
SIC: 3841 Surgical & Medical Instruments & Apparatus